y 27632 has been researched along with Adenovirus Infections in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bond, WS; Hurwitz, MY; Hurwitz, RL; Ildefonso, CJ; Liu, A | 1 |
| Adachi, S; Isobe, M; Ito, H; Kitajima, S; Maejima, Y; Morikawa-Futamatsu, K; Suzuki, J; Tamamori-Adachi, M | 1 |
2 other study(ies) available for y 27632 and Adenovirus Infections
| Article | Year |
|---|---|
Inhibitors of metalloprotease, γ-sectretase, protein kinase C and Rho kinase inhibit wild-type adenoviral replication.
Topics: Adenoviridae; Adenoviridae Infections; Administration, Ophthalmic; Amides; Antiviral Agents; Conjunctiva; Diamines; Dipeptides; DNA, Viral; Genetic Therapy; Genetic Vectors; HeLa Cells; Humans; Hyaluronan Receptors; Hyaluronic Acid; Hydroxamic Acids; Indoles; Maleimides; Metalloproteases; Permeability; Protein Kinase C; Proteolysis; Pyridines; rho-Associated Kinases; Signal Transduction; Thiazoles; Versicans; Viral Proteins; Virus Replication; Vitreous Body | 2020 |
HMG-CoA reductase inhibitor fluvastatin prevents angiotensin II-induced cardiac hypertrophy via Rho kinase and inhibition of cyclin D1.
Topics: Adenoviridae Infections; Amides; Angiotensin II; Animals; Animals, Newborn; Cardiomegaly; Cells, Cultured; Cyclin D1; Electrophoresis, Polyacrylamide Gel; Enzyme Inhibitors; Fatty Acids, Monounsaturated; Fluvastatin; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Immunoblotting; Indoles; Intracellular Signaling Peptides and Proteins; Leucine; Male; Mevalonic Acid; Myocardium; Myocytes, Cardiac; Protein Serine-Threonine Kinases; Pyridines; Rats; Rats, Wistar; Reverse Transcriptase Polymerase Chain Reaction; rho-Associated Kinases; RNA, Messenger | 2006 |